Management of infections due to antibiotic-resistant Streptococcus pneumoniae

Clinical Microbiology Reviews

Volumn 11, Issue 4, 1998, Pages 628-644

  Kaplan, Sheldon L ^a,b   Mason Jr , Edward O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID; DEXAMETHASONE; ERYTHROMYCIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PENICILLIN V POTASSIUM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOGRAMIN; SULFAFURAZOLE; TOBRAMYCIN; TRINEM DERIVATIVE; TROVAFLOXACIN; UNINDEXED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL MENINGITIS; CHILD; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0031736801     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.4.628     Document Type: Review

References (148)

1. Abbasi, S., S. L. Orlicek, I. Almohsen, G. Luedtke, and B. K. English. 1996. Septic arthritis and osteomyelitis caused by penicillin and cephalosporin-resistant Streptococcus pneumoniae in a children's hospital. Pediatr. Infect. Dis. J. 15:78-83.
2. Ahronheim, G. A., B. Reich, and M. I. Marks. 1979. Penicillin-insensitive pneumococci. Case report and review. Am. J. Dis. Child. 133:187-191.
3. Alonso, J., V. Madrigal, and M. Garcia-Fuentes. 1991. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr. Infect. Dis. J. 10:256. (Letter.)
4. Alper, C. M., W. J. Doyle, J. T. Seroky, and C. D. Bluestone. 1996. Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. Antimicrob. Agents Chemother. 40:1889-1892.
5. American Academy of Pediatrics. 1997. Dexamethasone therapy for bacterial meningitis, p. 620-622. In G. Peter (ed.), Red book: Report of the Committee on Infectious Diseases, 24th ed. American Academy of Pediatrics, Elk Grove Village, Ill.
6. Amsden, G. W., and J. J. Schentag. 1995. Tables of antimicrobial agent pharmacology, p. 492-528. In D. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, Inc., New York, N.Y.
7. Applebaum, P. C. 1996. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr. Infect. Dis. J. 15:932-939.
8. Arguedas-Mohs, A., S. L. Vargas, for the Chile PID-CRC Network Physicians, J. S. Bradley, C. Loaiza, R. Rivera, J. Vincent, R. Teng, and J. N. Walterspiel. 1997. Trovafloxacin CSF penetration and pharmacokinetics (PK) in children, abstr. A-105. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Arditi, M., E. O. Mason, Jr., J. S. Bradley, T. Q. Tan, W. J. Barson, G. E. Schutze, E. R. Wald, L. B. Givner, K. S. Kim, R. Yogev, and S. L. Kaplan. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics (in press).
10. Aronin, S. I., S. K. Mukherjee, J. C. West, and E. L. Cooney. 1998. Review of pneumococcal endocarditis in adults in the penicillin era. Clin. Infect. Dis. 26:165-171.
11. Arsensi, F., M. C. Otero, D. Perez-Tamarit, I. Rodriguez-Escribano, J. L. Cabedo, S. Gresa, and E. Canton. 1993. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. J. Chemother. 5:133-134.
12. Arsensi, F., D. Perez-Tamarit, M. C. Otero, M. Gallego, S. Lianes, C. Abadia, and E. Cantó. 1989. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr. Infect. Dis. J. 8:895. (Letter.)
13. Azoulay-Dupuis, E., E. Vallee, B. Veber, J. P. Bedos, J. Bauchet, and J-J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible, and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
14. Baril, L., P. Astagneau, J. Nguyen, T. Similowski, X. Mengual, C. Beigelman, E. Caumes, C. Katlama, and F. Bricaire. 1998. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical radiological, microbiological, and epidemiological study. Clin. Infect. Dis. 26:964-971.
15. Barnett, E. D., D. W. Teele, J. O. Klein, H. J. Cabral, S. J. Kharasch, and the Greater Boston Otitis Media Study Group. 1997. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics 99:23-28.
16. Barrett, M. S., and R. N. Jones. 1996. Antimicrobial activity and spectrum of sparfloxacillin tested against erythromycin-resistant Streptococcus pneumoniae isolates. Diagn. Microbiol. Infect. Dis. 24:113-116.
17. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1996. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob. Agents Chemother. 40:2431-2433.
18. Barry, B., M. Muffat-Joly, J. Bauchet, F. Faurisson, P. Gehanno, J.-J. Pocidalo, and C. Carbon. 1996. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin-and cephalosporin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:1977-1982.
19. Barry, B., M. Muffat-Joly, P. Gehanno, J-J. Pocidalo, and C. Carbon. 1993 Effect of increased dosage of amoxicillin in the treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 37:1599-1603.
20. Bartlett, J. G., R. F. Breiman, L. A. Mandell, and T. M. File, Jr. 1998. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811-838.
21. Berges, S. A., M. Dan, F. Serour, A. Gorea, A. Levenberg, and M. Krispin. 1989. Penetration of third-generation cephalosporins into human peritoneal tissue. Chemotherapy 35:326-329.
22. Biedenbach, D., A. Wanger, and R. N. Jones. 1996. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest. J. Antimicrob. Chemother. 38:553-555.
23. Block, S. L., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 14:751-759.
24. Bradley, J. S., and J. D. Connor. 1991. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10:871-873.
25. Bradley, J. S., and W. M. Scheld. 1997. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990's. Clin. Infect. Dis. 24(Suppl. 2):S213-S221.
26. Bradsher, R. W. 1982. Ceftriaxone (Ro 13-9904) therapy of serious infections. Antimicrob. Agents Chemother. 22:36-42.
27. Buckingham, S. C., S. P. Brown, and V. H. San Joaquin. 1998. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J. Pediatr. 132:174-176.
28. Butler, J. C., J. Hofman, M. S. Cetron, J. A. Elliott, R. R. Facklam, R. F. Breiman, and the Pneumococcal Sentinel Surveillance Working Group. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 74: 986-993.
29. Cabellos, C., J. Martinez-Lacasa, A. Martos, F. Tubau, A. Fernández, P. F. Viladrich, and F. Gudiol. 1995. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob. Agents Chemother. 39:2158-2160.
30. Canafax, D. M., Z. Yuan, T. Chonmaitree, K. Deka, H. Q. Russlie, and G. S. Giebink. 1998. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr. Infect. Dis. J. 17:149-156.
31. Carratalá, J., A. Marron, A. Fernández-Sevilla, J. Liñares, and F. Gudiol. 1997. Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer. Clin. Infect. Dis. 24:148-152.
32. Catalan, M. J., J. M. Fernandez, A. Vazquez, E. V. Seijas, A. Suárez, and J. C. L. B. Quirós. 1994. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 18:766-769.
33. Chesney P. J., J. A. Wilimas, C. Presbury, S. Abbasi, R. J. Leggiadro, Y. Davis, S. W. Day, G. E. Schutze, and W. C. Wang. 1995. Penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J. Pediatr. 127:526-532.
34. Committee on Infectious Diseases of the American Academy of Pediatrics. 1997. Therapy for children with invasive pneumococcal infections. Pediatrics 99:289-299.
35. Craig, W. A., and D. Andes. 1996. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:944-948.
36. Dagan, R., O. Abramson, E. Leibovitz, R. Lang, S. Goshen, D. Greenberg, P. Yagupsky, A. Leiberman, and D. M. Fliss. 1996. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr. Infect. Dis. J. 15: 980-985.
37. Dagan, R., L. Piglansky, P. Yagupsky, D. M. Fliss, A. Leiberman, and E. Leibovitz. 1997. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor and amoxicillin, abstr. K-103. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
38. Dagan, R., L. Velghe, J. L. Rodda, and K. P. Klugman. 1994. Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J. Antimicrob. Chemother. 34:175-179.
39. Daum, R. S., J. P. Nachman, C. D. Leiteh, and F. C. Tenover. 1994. Nosocomial epiglottitis associated with penicillin-and cephalosporin-resistant Streptococcus pneumoniae bacteremia. J. Clin. Microbiol. 32:246-248.
40. Dhawan, V. K. 1982. Clindamycin: a review of fifteen years of experience. Rev. Infect. Dis. 4:1133-1153.
41. Doern, G. V., G. Pierce, and A. B. Brueggemann. 1996. In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella calarrhalis. Diagn. Microbiol. Infect. Dis. 26:39-42.
42. Doit, C., J. Barre, R. Cohen, S. Bonacorsi, A. Bourrillon, and E. H. Bingen. 1997. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin. Antimicrob. Agents Chemother. 41:2050-2052.
43. Dyk, J. C., S. A. Terespolsky, C. S. Meyer, C. H. van Niekerk, and K. P. Klugman. 1997. Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media. Pediatr. Infect. Dis. J. 16:79-81.
44. Esterle, T. M., and K. M. Edwards. 1996. Concerns of secondary fever in Streptococcus pneumoniae meningitis in an era of increasing antibiotic resistance Arch. Pediatr. Adolesc. Med. 150:552-554.
45. Fasola, E., S. K. Spangler, L. M. Ednie, M. R. Jacobs, S. Bajaksouzian, and P. C. Appelbaum. 1996. Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 40:2661-2663.
46. Feldman, C., J. Kallenbach, S. D. Miller, J. R. Thorburn, and H. J. Kornhof. 1985. Community-acquired pneumonia due to penicillin-resistant pneumococci. N. Engl. J. Med. 313:615-617.
47. File, T. M., Jr., J. Segreti, L. Dunbar, R. Player, R. Kohler, R. R. Williams, C. Kojak, and A. Rubin. 1997. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother. 41:1965-1972.
48. Fitoussi, F., C. Doit, K. Benali, S. Bonacorsi, P. Geslin, and E. Bingen. 1998. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis. Antimicrob. Agents Chemother. 42:942-944.
49. Frankel, R. E., M. Virata, C. Hardalo, F. L. Altice, and G. Friedland. 1996. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin. Infect. Dis. 23:577-584.
50. Fraschini, F., P. C. Braga, G. Scarpazza, F. Scaglione, O. Pignataro, G. Sambataro, C. Mariani, G. C. Roviaro, F. Varoli, and G. Esposti. 1986. Human pharmacokinetics and distribution in various tissues of ceftriaxone. Chemotherapy 32:192-199.
51. Friedland, I. R. 1995. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr. Infect. Dis. J. 14:885-890.
52. Friedland, I. R., and K. P. Klugman. 1992. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 339:405-408.
53. Friedland, I. R., and K. P. Klugman. 1997. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dose cefotaxime. Antimicrob. Agents Chemother. 41:1888-1891.
54. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis Antimicrob. Agents Chemother. 37:1630-1636.
55. Friedland I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 12:196-200.
56. Fugii K., A. Tsuji, S. Miyazake, K. Yamaguchi, and S. Goto. 1994. In vitro antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. Antimicrob. Agents Chemother. 38:1118-1122.
57. Gaillard J. L., V. Abadie, G. Cheron, F. Lasaille, B. Mahut, C. Silly, V. Matha, C. Coustere, and F. Lokiec. 1994. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob. Agents Chemother. 38:1209-1210.
58. Garcia-Leoni, M. E., E. Cerenado, P. Rodeño, J. C. L. B. Quirós, D. Martinéz-Hernandéz, and E. Bouza. 1992. Susceptibility of Streptococcus pnuemoniae to penicillin: a prospective microbiological and clinical study. Clin. Infect. Dis. 14:427-435.
59. Gartner, J. C., and R. H. Michaels. 1979. Meningitis from a pneumococcus moderately resistant to penicillin. JAMA 241:1707-1709.
60. Gavalda, J., J. A. Capdevila, B. Almirante, J. Otero, I. Ruiz, M. Laguarda, H. Allende, E. Crespo, C. Pigrau, and A. Pahissa. 1997. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats. Antimicrob. Agents Chemother. 41:795-801.
61. Gehanno, P., B. Barry, S. Bobin, and C. Safran. 1994. Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children. Scand. J. Infect. Dis. 26:577-584
62. Gehanno, P., P. Berche, L. N'Gyen, M. Derriennic, F. Pichon, and J. M. Goehrs. 1997. Resolution of clinical failure in acute otitis media confirmed by in vivo bacterial eradication-efficacy and safety of ceftriaxone injected once daily for 3 days, abstr. LM-45. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
63. Gehanno, P., G. Lenoir, and P. Berche. 1995. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob. Agents Chemother. 39:271-272.
64. Gelfand, M. S., and K. O. Cleveland. 1992. Penicillin-resistant pneumococcal vertebral osteomyelitis. Clin. Infect. Dis. 15:746-747.
65. George, J., and I. Morrissey. 1997. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. J. Antimicrob. Chemother. 39: 719-723.
66. Girgis, N. I., Z. Farid, I. A. Mikhail, I. Farrag, Y. Sultan, and M. E. Kilpatrick. 1989. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr. Infect. Dis. J. 8:848-851.
67. Green, S. M., and S. G. Rolhrock. 1993. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 91:23-30.
68. Gudnason, T., F. Gudbrandsson, F. Barsanti, and K. G. Kristinsson. 1998. Penetration of ceftriaxone into the middle ear fluid of children. Pediatr. Infect. Dis. J. 17:258-260.
69. Guibert, M., H. Chahime, J. Petit, M. Odiévre, and P. Labrune. 1995. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae. Acta Paediatr. 84:831-833
70. Hardie, W. D., N. E. Roberts, S. F. Reising, and C. D. C. Christie. 1998. Complicated parapneumoniac effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 101:388-392.
71. Harrison, C. J., S. A. Chartrand, W. Rodriguez, R. Schwartz, J. Pollack, B. Thedinger, S. L. Block, and J. A. Hedrick. 1997. Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion. Pediatr. Infect. Dis. J. 16:816-817.
72. Harrison, C. J., D. Welch, and M. I. Marks. 1983. Ceftriaxone therapy in pediatric patients. Am. J. Dis. Child. 137:1048-1051.
73. Hieber, J. P., and J. D. Nelson. 1977. A pharmacologic evaluation of penicillin 'in children with purulent meningitis. N. Engl. J. Med. 297:410-413
74. Hoberman, A., J. L. Paradise, S. Block, D. J. Burch, M. R. Jacobs, and M. I. Balanescu. 1996. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr. Infect. Dis. J. 15:955-962.
75. Jackson, M. A., S. Shelton, J. D. Nelson, and G. H. McCracken, Jr. 1984. Relatively penicillin-resistant pneumococcal infections m pediatric patients. Pediatr. Infect. Dis. J. 3:129-132.
76. John, C. C. 1994. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
77. Kanra, G. Y., H. Ozen, G. Secmeer, M. Ceyhan, Z. Ecevit, and E. Belgin. 1995. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr. Infect. Dis. J. 14:490-494.
78. Kaplan, S. L., E. O. Mason, Jr., W. J. Barson, E. R. Wald, M. Arditi, T. Q. Tan G. E. Schutze, J. S. Bradley, L. B. Givner, K. S. Kim, and R. Yogev. Three year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics, in press.
79. Kaykova, Y., M. Santos, D. Desiderio, M. Simberkoff, and R. S. Holzman. 1997. Risk factors for mortality frum pneumococcal bacteremia, abstr. 671. In Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America.
80. Kim, Y. S., Q. Liu, L. L. Chow, and M. G. Täuber. 1997. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1186-1189.
81. Kleiman, M. B., G. A. Weinberg, J. K. Reynolds, and S. D. Allen. 1993. Meningitis with beta-lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr. Infect. Dis. J. 12:782-784.
82. Klugman, K., I. R. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
83. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbial. Rev. 3:171-196.
84. Klugman, K. P., R. Dagan, and the Meropenem Meningitis Study Group. 1995 Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob. Agents Chemother. 39:1140-1146.
85. Leggiadro, R. J., F. F. Barrett, P. J. Chesney, Y. Davis, and F. C. Tenover. 1994. Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-South children's hospital. Pediatr. Infect. Dis. J. 13:320-322.
86. Leibovitz, E., L. Piglansky, S. Raiz, D. Greenberg, P. Yagupsky, J. Press D M. Fliss, A. Leiberman, and R. Dagan. 1997. Bacteriologic efficacy of 3-day intramuscular ceftriaxone in non-responsive acute otitis media, abstr. K-105. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
87. Leibovitz, E., L. Piglansky, M. Scandola, L. Daros, P. French, A. Capriati, and R. Dagan. 1997. Sanfretrinem pharmacokinetics (plasma and middle ear fluid) in pediatric patients with acute otitis media, abstr. F-204. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
88. Looks, J. R., M. R. Durkin, A. N. Meyerhoff, and A. A. Medeiros. 1995. Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae. N. Engl. J. Med. 332:893-894. (Letter.)
89. Lutsar I., I. R. Friedland, L. Wubbel, A. Ahmed, M. Trujillo, H. Jafri, C. C. McCoig and G. H. McCracken, Jr. 1997. Timing of dexamethasone therapy in experimental pneumococcal meningitis, abstr. 272. In Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America.
90. Mace, J. W., D. S. Janik, R. L. Sauer, and J. J. Quilligan, Jr. 1977. Penicillin-resistant pneumococcal meningitis in an immunocompromised infant. J. Pediatr. 91:506-507. (Letter.)
91. Mandell, L., D. W. Hopkins, and S. Hopkins. 1997. Efficacy of trovafloxacin in patients with community acquired pneumonia due to penicillin susceptible and resistant S. pneumoniae, abstr. LM-71. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
92. Mason, E. O., Jr., L. B. Lamberth, and S. L. Kaplan. 1996. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:1039-1040.
93. Mason, E. O., Jr., L. B. Lamberth, N. L. Kershaw, and B. L. T. Prosser. 1997. S. pneumoniae antibiotic susceptibility in the United States: 1996-1997, abstr. E48. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
94. McCracken, G. H., Jr., J. D. Nelson, S. L. Kaplan, G. D. Overturf W. J. Rodriguez, and R. W. Steele. 1987. Consensus Report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr. Infect. Dis. J. 6:501-505.
95. McIntyre, P. B., C. S. Berkey, S. M. King, U. B. Schaad, T. Kilpi, G. Y. Kanra and C M. O. Perez. 1997. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925-931.
96. Moellering, R. C., Jr., D. J. Krogstad, and D. J. Greenblatt. 1981. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. Rev. Infect. Dis. 3:S230-S235.
97. Moine J. M., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J.-P. Bédos, J. Bauchert, and J.-J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resisitant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
98. Morgan, J. R., A. Paull, M. O'Sullivan, and B. D. Williams. 1985. The penetration of ceftriaxone into synovial fluid of the inflamed joint. J. Antimicrob. Chemother. 16:367-371.
99. Moroney, J., A. Fiore, M. Farley, L. Harrison, J. Patterson, M. Cetron and A. Schuchat. 1997. Therapy and outcome of meningitis caused by drug-resistant Streptococcus pneumoniae in three US cities 1994-1996, abstr. 48. In Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America.
100. Munoz, M., E. S. Valderrabanos, E. Diaz, J. J. Silva, J. A. Souet, P. Infante, J. D. Lopez, and A. Garcia-Curiel. 1995. Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis. J. Pediatr. 127:98-99.
101. Naraqi, S., G. P. Kirkpatrick, and S. Kabins. 1974. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J. Pediatr. 85:671-673.
102. National Committee for Clinical Laboratory Standards. 1997. Minimum inhibitory concentration (MIC) interpretive standards (μg/ml) for Streptococcus spp., vol. 17, no. 2. M100-S7. National Committee for Clinical Laboratory Standards, Villanova, Pa.
103. Nelson C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
104. Novick, W. J., Jr. 1982. Levels of cefotaxime in body fluids and tissues: a review. Rev. Infect. Dis. 4:S346-S353.
105. Olsson-Liljequist, B., B. M. Hoffman, and J. Hedlund. 1996. Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden. Eur J Clin Microbiol. Infect. Dis. 15:671-675.
106. Oppenheim, B., H. J. Koornhof, and R. Austrian. 1986. Antibiotic-resistant pneumococcal disease in children at Baragwanath Hospital, Johannesburg. Pediatr. Infect. Dis. J. 5:520-524.
107. Pacheco, T. R., C. K. Cooper, D. J. Hardy, R. F. Betts, and W. Bennez. 1997. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis. Am. J. Med. 102:303-305.
108. Pallares, R., F. Guidiol, J. Liñares, J. Ariza, G. Rufi, L. Murgui, J. Dorca, and P. F. Viladrich. 1987. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N. Engl. J. Med. 317:18-22.
109. Pallares, R., J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich R. Martin, and F. Guidiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
110. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and timekill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:2071-2074.
111. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1995. Activity of C99, 219 compared with DU-6859A, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfoxacin, and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J. Antimicrob. Chemother. 35: 230-232.
112. Parades, A., L. H. Taber, M. D. Yow, D. Clark, and W. Nathan. 1976. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics 85:671-673.
113. Paris, M. M., S. M. Hickey, M. Trujillo, S. Shelton, and G. H. McCracken, Jr. 1995. Evaluation of CP-99, 219, a new fluoroquinolone, for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 39:1243-1246.
114. Paris, M. M., S. M. Hickey, M. I. Uscher, S. Shelton, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 38:1320-1324.
115. Pichichero, M. E., S. Mclinn, G. Aronovitz, R. Fiddes, J. Blumer, K. Nelson, and B. Dashefsky. 1997. Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr. Infect. Dis. J. 16:471-478.
116. Pichichero, M. E., and C. L. Pichichero. 1995. Persistent acute otitis media. I. Causative pathogens. Pediatr. Infect. Dis. J. 14:178-183.
117. Pikis, A., S. Akram, J. A. Donkersloot, J. M. Campos, and W. J. Rodnguez. 1995. Penicillin-resistant pneumococci from pediatric patients in the Washington, D.C. area. Arch. Pediatr. Adolesc. Med. 149:30-35.
118. Pikis A., J. A. Donkersloot, S. Akram, J. M. Keith, J. M. Campos, and W. J. Rodriguez. 1997. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 40:105-108.
119. Plouffe, J. F., I. Baird, J. Barnishan, J. Porterfield-Baxa, M. Best S. Dalieh, J. Emerick, R. J. Fass, G. Gianakopoulos, B. A. Hackman, S. Hadley, M Herbert, S. L. Koletar, W. Maher, J. A. Minor, B. A. Oglevee, M. F. Para, J. Parsons, T. Rogers, G. Scott-Tibbs, and C. S. Tumbleson. 1996. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 25:43-45.
120. Plouffe, J. F., R. F. Breiman, and R. R. Facklam for the Franklin County Pneumonia Study Group. 1996. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 275:194-198.
121. Ponte, C. A., Parra, E. Nieto, and F. Soriano. 1996. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumomae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem. Antimicrob. Agents Chemother. 40:2698-2702.
122. Quagliarello, V. J., and W. M. Scheld. 1997. Treatment of bacterial meningitis. N. Engl. J. Med. 336:708-716.
123. Regamey, C. 1985. Pharmacokinetics of ceftriaxone and its relation to concentrations in extracellular compartments. Chemotherapy 31:85-94.
124. Sáez-Llorens, X., E. Costaño, R. García, C. Báez, M. Pérez, F. Tejeira, and G. J. McCracken, Jr. 1995. Prospective randomized comparison of cefepmine and cefotaxime for the treatment of bacterial meningitis in infants and children. Antimicrob. Agents Chemother. 39:937-940.
125. Sauve, C., E. Azoulay-Dupuis, P. Moine, C. Darras-Joly, V. Rieux, C. Carbon, and J.-P. Bédos. 1996. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2829-2834.
126. Scaglione, F., M. Raichi, and F. Fraschini. 1990. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. J. Antimicrob. Chemother. 26(Suppl. A):1-10.
127. Schaad, V. B., S. L. Kaplan, and G. H. McCracken, Jr. 1995. Steroid therapy for bacterial meningitis. Clin. Infect. Dis. 20:685-690.
128. Schmidt, H., G. Zysk, R. R. Reinert, W. Brück, A. Stringaris, V. Chen, K. Stuertz, F. Fischer, R. Bartels, K. J. Schaper, S. Weinig, and R. Nau. 1997. Rifabutin for experimental pneumococcal meningitis. Chemotherapy 43: 264-271.
129. Schwartz, R. H., W. N. Khan, and S. Akram. 1991. Penicillin and trimethoprim-sulfamethoxazole-resistant pneumococci isolated from blood cultures of three infants in metropolitan Washington, D.C.: a harbinger of serious future problems? Pediatr. Infect. Dis. J. 10:782-783.
130. Seikel, K., S. Shelton, and G. H. McCracken, Jr. 1997. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr. Infect. Dis. J. 16:710-711.
131. Silverstein, M., A. Chumpa, R. Bachur, and M. B. Harper. 1997 Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia, abstr. K-90. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
132. Singh K. V., T. M. Coque, and B. E. Murray. 1996. In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms. Antimi-crob. Agents Chemother. 40:2142-2146.
133. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C. Tenover, and R. J. Leggiadro. 1992. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11:662-666.
134. Soriano, R., P. Coronel, M. Gimeno, M. Jiménez, P. García-Corbeira, and R. Fernández-Roblas. 1996. Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influence, and Neisseria meningitidis. Eur. J. Clin. Microbiol. Infect. Dis. 15:761-763.
135. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1996. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin) two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:481-484.
136. Tan, T. Q., E. O. Mason, Jr., and S. L. Kaplan. 1992. Systemic infections due to Streptococcus pneumomae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics 90:928-933.
137. Tan, T. Q., G. E. Schutze, E. O. Mason, Jr., and S. L. Kaplan. 1994. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 38:918-923.
138. Tan, T. Q., E. O. Mason, Jr., W. J. Barson, E. R. Wald, G. E. Schutze, J. S. Bradley, M. Arditi, L. B. Givner, R. Yogev, K. S. Kim, and S. L. Kaplan. Clinical characteristics and outcome of children with pneumonia due to penicillin-susceptible and non-susceptible Streptococcus pneumoniae. Pediatrics, in press.
139. Tateda, K., K. Takashima, H. Miyazaki, T. Matsumoto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacy of antibiotics in this model. Antimicrob. Agents Chemother. 40:1520-1525.
140. Thomson, K. S., S. A. Chartrand, C. C. Sanders, and S. L. Block. 1997. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:478-480.
141. Thoroddsen, E., C. Marr, C. Efthymiopoulos, and H. Thorarinsson. 1997. Concentration of cefuroxime in middle ear effusion of children with acute otitis
142. Topkis, S., H. Swarz, S. A. Breisch, and A. N. Maroli. 1997. Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia. Clin. Ther. 19:975-988.
143. Viladrich, P. F., C. Cabellos, R. Pallares, F. Tubau, J. Martínez-Lacasa, J. Liñares, and F. Gudiol. 1996. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:218-220.
144. Viladrich, P. F., F. Gudiol, J. Liñares, R. Pallarés, I. Sabaté, G. Rufí, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 35:2467-2472.
145. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:362-366.
146. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1946. Antipneumococcal activity of Bay 12-8039, a new quinolone compared to 3 other quinolones and 5 β-lactams, abstr. F6. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
147. Wald, E. R., S. L. Kaplan, E. O. Mason, Jr., D. Sabo, L. Ross, M. Arditi, B. L. Wiedermann, W. Barson, K. S. Kim, R. Yogev, and D. Hofkosh. Meningitis Study Group. 1995. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 95:21-28.
148. Welby, P. L., D. S. Keller, J. L. Cromien, P. Tebas, and G. A. Storch. 1994. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr. Infect. Dis. J. 13:281-287.